Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7914515> ?p ?o }
Showing triples 1 to 68 of
68
with 100 triples per page.
- Q7914515 subject Q6403537.
- Q7914515 subject Q7334131.
- Q7914515 subject Q7482068.
- Q7914515 subject Q8252271.
- Q7914515 subject Q8616356.
- Q7914515 subject Q8636858.
- Q7914515 subject Q8878420.
- Q7914515 subject Q8965786.
- Q7914515 subject Q9052323.
- Q7914515 abstract "Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of a number of cell receptors, mainly the vascular endothelial growth factor receptor (VEGFR), the epidermal growth factor receptor (EGFR), and the RET-tyrosine kinase. The drug was developed by AstraZeneca.".
- Q7914515 atcPrefix "L01".
- Q7914515 atcSuffix "XE12".
- Q7914515 casNumber "443913-73-3".
- Q7914515 chEBI "49960".
- Q7914515 drugbank "DB08764".
- Q7914515 fdaUniiCode "YO460OQ37K".
- Q7914515 iupacName "N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine".
- Q7914515 pubchem "3081361".
- Q7914515 thumbnail Vandetanib2DACS.svg?width=300.
- Q7914515 wikiPageExternalLink vandetanib.
- Q7914515 wikiPageWikiLink Q12074763.
- Q7914515 wikiPageWikiLink Q14864419.
- Q7914515 wikiPageWikiLink Q14865565.
- Q7914515 wikiPageWikiLink Q14914444.
- Q7914515 wikiPageWikiLink Q16399.
- Q7914515 wikiPageWikiLink Q169219.
- Q7914515 wikiPageWikiLink Q18253720.
- Q7914515 wikiPageWikiLink Q30612.
- Q7914515 wikiPageWikiLink Q3493538.
- Q7914515 wikiPageWikiLink Q3658562.
- Q7914515 wikiPageWikiLink Q415220.
- Q7914515 wikiPageWikiLink Q420436.
- Q7914515 wikiPageWikiLink Q4356503.
- Q7914515 wikiPageWikiLink Q4677569.
- Q7914515 wikiPageWikiLink Q492646.
- Q7914515 wikiPageWikiLink Q5458077.
- Q7914515 wikiPageWikiLink Q6403537.
- Q7914515 wikiPageWikiLink Q653197.
- Q7914515 wikiPageWikiLink Q653924.
- Q7914515 wikiPageWikiLink Q7180990.
- Q7914515 wikiPageWikiLink Q7251487.
- Q7914515 wikiPageWikiLink Q731938.
- Q7914515 wikiPageWikiLink Q7334131.
- Q7914515 wikiPageWikiLink Q7482068.
- Q7914515 wikiPageWikiLink Q824258.
- Q7914515 wikiPageWikiLink Q8252271.
- Q7914515 wikiPageWikiLink Q8616356.
- Q7914515 wikiPageWikiLink Q8636858.
- Q7914515 wikiPageWikiLink Q8878420.
- Q7914515 wikiPageWikiLink Q8965786.
- Q7914515 wikiPageWikiLink Q9052323.
- Q7914515 wikiPageWikiLink Q974135.
- Q7914515 atcPrefix "L01".
- Q7914515 atcSuffix "XE12".
- Q7914515 casNumber "443913".
- Q7914515 chebi "49960".
- Q7914515 drugbank "DB08764".
- Q7914515 iupacName "N--6-methoxy-7-[methoxy]quinazolin-4-amine".
- Q7914515 pubchem "3081361".
- Q7914515 unii "YO460OQ37K".
- Q7914515 type ChemicalSubstance.
- Q7914515 type Drug.
- Q7914515 type ChemicalObject.
- Q7914515 type Thing.
- Q7914515 type Q8386.
- Q7914515 comment "Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of a number of cell receptors, mainly the vascular endothelial growth factor receptor (VEGFR), the epidermal growth factor receptor (EGFR), and the RET-tyrosine kinase. The drug was developed by AstraZeneca.".
- Q7914515 label "Vandetanib".
- Q7914515 depiction Vandetanib2DACS.svg.